Order Article Reprints

Mahmoud AB, Alhamawi RM, Taher MY, Alsubhi AS, Abouzied MM, Zahid HM, Alotaibi MA, Almarghalani N, Alotaibi K, Habash A, et al. Integrated In Silico and In Vivo Evaluation of a Tetravalent SARS-CoV-2 RBD–Fc Fusion Vaccine with Broad Cross-Variant Antibody Responses. Vaccines. 2025; 13(12):1244. https://doi.org/10.3390/vaccines13121244

Mahmoud, Ahmad Bakur, Renad M. Alhamawi, Mustafa Yassin Taher, Awadh S. Alsubhi, Mekky M. Abouzied, Heba M. Zahid, Mohammed Abdullah Alotaibi, Nada Almarghalani, Khulood Alotaibi, Abdulrahman Habash, and et al. 2025. "Integrated In Silico and In Vivo Evaluation of a Tetravalent SARS-CoV-2 RBD–Fc Fusion Vaccine with Broad Cross-Variant Antibody Responses" Vaccines 13, no. 12: 1244. https://doi.org/10.3390/vaccines13121244

Mahmoud, A. B., Alhamawi, R. M., Taher, M. Y., Alsubhi, A. S., Abouzied, M. M., Zahid, H. M., Alotaibi, M. A., Almarghalani, N., Alotaibi, K., Habash, A., Alsharif, S. A., & Alkayyal, A. (2025). Integrated In Silico and In Vivo Evaluation of a Tetravalent SARS-CoV-2 RBD–Fc Fusion Vaccine with Broad Cross-Variant Antibody Responses. Vaccines, 13(12), 1244. https://doi.org/10.3390/vaccines13121244